| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/24/2009 | US20090238833 Protein |
| 09/24/2009 | US20090238832 Novel compositions and method for the treatment of psoriasis |
| 09/24/2009 | US20090238831 Monoclonal antibodies and uses thereof |
| 09/24/2009 | US20090238830 Protein |
| 09/24/2009 | US20090238829 Stabilized single domain antibodies |
| 09/24/2009 | US20090238827 Therapeutic use of anti-cs1 antibodies |
| 09/24/2009 | US20090238826 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 09/24/2009 | US20090238825 Novel rabbit antibody humanization methods and humanized rabbit antibodies |
| 09/24/2009 | US20090238824 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/24/2009 | US20090238823 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 09/24/2009 | US20090238822 Chimeric Hepatitis C Virus Antigens For Eliciting an Immune Response |
| 09/24/2009 | US20090238821 Humanized antibodies that sequester amyloid beta peptide |
| 09/24/2009 | US20090238819 Therapeutic and diagnostic agents |
| 09/24/2009 | US20090238755 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 09/24/2009 | CA2718923A1 Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes |
| 09/24/2009 | CA2718869A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 09/24/2009 | CA2718707A1 Method for detection of liver cancer cell using anti-glypican-3 antibody |
| 09/24/2009 | CA2718634A1 Antibodies against interleukin-10-like cytokines and uses therefor |
| 09/24/2009 | CA2718473A1 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 09/24/2009 | CA2717569A1 Methods for treating psoriasis |
| 09/24/2009 | CA2714708A1 Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 09/23/2009 | EP2103688A2 Method for modifying plant morphology, biochemistry and physiology |
| 09/23/2009 | EP2103629A1 Gamma -1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 09/23/2009 | EP2103628A1 Anti-claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same |
| 09/23/2009 | EP2102655A1 In vitro method for diagnosing prostate cancer |
| 09/23/2009 | EP2102244A2 Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
| 09/23/2009 | EP2102243A2 Anti-fc-receptor single domain antibodies (nanobodies-tm) and therapeutic use |
| 09/23/2009 | EP2102242A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 09/23/2009 | EP2102241A2 Amino acid sequences that modulate the interaction between cells of the immune system |
| 09/23/2009 | EP2102240A2 Overexpression of the chaperone bip in a heterokaryon |
| 09/23/2009 | EP2102239A2 Improved immunoglobulin libraries |
| 09/23/2009 | EP2102238A2 Cd44 antibodies |
| 09/23/2009 | EP2102235A1 Treatment of cachexia |
| 09/23/2009 | EP2102228A1 Method of diagnosing pre-eclampsia |
| 09/23/2009 | EP2101877A2 Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo |
| 09/23/2009 | EP2101823A2 Rna-coded antibody |
| 09/23/2009 | EP2101818A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 09/23/2009 | EP2101817A2 Human antibodies that bind cd19 and uses thereof |
| 09/23/2009 | EP2101816A1 Antagonist antibodies against ephb3 |
| 09/23/2009 | EP2101811A2 Vaccine for periodontitis and methods of use |
| 09/23/2009 | EP2101780A2 Methods of treating chronic inflammatory diseases using a gm-csf antagonist |
| 09/23/2009 | EP1706428B1 Anti-cancer antibodies with reduced complement fixation |
| 09/23/2009 | EP1542528B1 A method of treatment and prophylaxis |
| 09/23/2009 | EP1326887B1 Polypeptide from haemophilus influenza |
| 09/23/2009 | EP1234880B9 Novel protein tab2 |
| 09/23/2009 | EP1086138B1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 09/23/2009 | EP1073734B1 Tumor associated nucleic acids and uses therefor |
| 09/23/2009 | EP1003781B1 Interleukin-18 binding proteins, their preparation and use |
| 09/23/2009 | CN101541835A Anti-idiotype conjugate and its use as a standard in an immunassay |
| 09/23/2009 | CN101541834A Prophylactic or therapeutic agent for cancer |
| 09/23/2009 | CN101541833A IL-17 receptor A antigen binding proteins |
| 09/23/2009 | CN101541832A Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
| 09/23/2009 | CN101538329A Variable region sequence for novel anti-beta amyloid polypeptide antibody and coding sequence thereof |
| 09/23/2009 | CN101538328A Humanized neutralizing engineered antibody for targeting avian influenza virus H5N1 |
| 09/23/2009 | CN101538327A Anthropogenic H5N1-resisting hemagglutinin protein broad-spectrum neutralising antibody and application thereof |
| 09/23/2009 | CN101538326A Variable region sequence of hepatitis B virus monoclonal antibody, gene engineering antibody containing variable region and application thereof |
| 09/23/2009 | CN101538319A Polypeptide for detecting polytype human papilloma virus and application thereof |
| 09/23/2009 | CN101538307A Dehydroepiandrosterone hapten, artificial antigen and antibody as well as preparation method and application thereof |
| 09/23/2009 | CN101538266A Rogridone hapten, artificial antigen and antibody as well as preparation method and application thereof |
| 09/23/2009 | CN101537180A Recombinant production of mixtures of antibodies |
| 09/23/2009 | CN100543035C B7. 1-CD19scFv fusion gene engineering albumen for treating B lymphocyte leukemia and lymph tumour and use thereof |
| 09/23/2009 | CN100542607C Anti-myelin associated glycoprotein (MAG) antibodies |
| 09/22/2009 | US7593723 Modular personal device system |
| 09/22/2009 | US7592439 Apolipoprotein receptor specific monoclonal antibody for use in the prevention and treatment of cell proliferative disorders |
| 09/22/2009 | US7592437 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/22/2009 | US7592433 cyclic peptides, signal peptide having animal or plant diagnostic/therapeutic properties; cyclization an encoded amino acid sequence within a cell or cell membrane; protecting crop plants, insecticidal proteins from pest |
| 09/22/2009 | US7592431 Biodegradable T-cell Activation device |
| 09/22/2009 | US7592430 Monoclonal antibody specific to macrophage colony stimulating factor (M-CSF) for use in treatment and prevention of infection, inflammation, nervous system, respiratory system, bone and skin disorders |
| 09/22/2009 | US7592429 Sclerostin-binding antibody |
| 09/22/2009 | US7592428 monoclonal antibodies binds specifically to the extracellular domain; useful in diagnostic methods, enzyme-linked immunosorbent assay; use in therapy to modulate activin or transforming growth factor activity; biodrugs for fibrosis, liver cirrhosis and pulmonary fibrosis, cancer, rheumatoid arthritis |
| 09/22/2009 | US7592423 Globular adiponectin variants |
| 09/22/2009 | US7592318 88kDa tumorigenic growth factor and antagonists |
| 09/22/2009 | US7592313 Method of stimulating proliferation of regulatory T cells in a diabetic mammal |
| 09/22/2009 | US7592310 Induction of antibiotic proteins and peptides by LAIT/sCD14-protein |
| 09/22/2009 | US7592167 Functional peptide fiber, production thereof and method for recovering peptide chains |
| 09/22/2009 | US7592149 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 09/22/2009 | US7592140 2′, 5′-oligoadenylate phosphodiesterase |
| 09/22/2009 | US7592012 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 09/22/2009 | US7592007 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
| 09/22/2009 | US7592006 Composition comprising the LO-CD2a antibody |
| 09/22/2009 | US7592005 Multiple myeloma; targeting antibody conjugated with a radionuclide or other cytotoxic substance |
| 09/22/2009 | US7592004 Lyophilizing an aqueous formulation comprising a high concentration, 50 mg/ml or more of an immunoglobulin IgG antibody, in particular, daclizumab, in 5-25 mM histidine buffer, having pH 5.5-6.5, 0.005%-0.03% polysorbate, and sucrose |
| 09/22/2009 | US7592003 Regulation of toll-like receptors on stem cells |
| 09/22/2009 | CA2646040A1 Detection of a biomarker of aberrant cells of neuroectodermal origin in a body fluid |
| 09/22/2009 | CA2508139C Escape mutants of newcastle disease virus as marker vaccines |
| 09/22/2009 | CA2346927C Method for generating diversity |
| 09/22/2009 | CA2239167C Aldolase catalytic antibody |
| 09/22/2009 | CA2200980C Mammalian receptors for modified low-density lipoprotein |
| 09/17/2009 | WO2009114828A1 Compositions and methods relating to gastrointestinal allergic conditions |
| 09/17/2009 | WO2009114748A1 Immuno-based botulinum toxin serotype a activity assays |
| 09/17/2009 | WO2009114641A1 Antibodies with enhanced adcc function |
| 09/17/2009 | WO2009114585A1 Anti-tyrp1 antibodies |
| 09/17/2009 | WO2009114560A2 Compositions and methods for the therapy and diagnosis of cytomegalovirus |
| 09/17/2009 | WO2009114188A1 Newcastle disease virus monoclonal antibodies |
| 09/17/2009 | WO2009114110A1 Engineered fusion molecules immunotherapy in cancer and inflammatory diseases |
| 09/17/2009 | WO2009113880A1 Biomarkers |
| 09/17/2009 | WO2009113879A1 Biomarkers |
| 09/17/2009 | WO2009113832A1 Method for monitoring, diagnosing, and screening cancer through measuring the concentration of des-r prothrombin activation peptide fragment f2 (des-r f2) in a serum |
| 09/17/2009 | WO2009113649A1 Antibody having an immune-enhancement function |
| 09/17/2009 | WO2009113637A1 Novel thiazole derivative, matrix having thiazole derivative immobilized thereon, method for production of the thiazole derivative, and method for production of the matrix |